about
Insulin-like growth factors and their potential role in cardiac epigeneticsPeroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancerPharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic FibrosisNuclear receptors and epigenetic regulation: opportunities for nutritional targeting and disease preventionCommonalities in the Association between PPARG and Vitamin D Related with Obesity and CarcinogenesisEpigenetics and Cellular MetabolismAssociations between serum perfluoroalkyl acids and LINE-1 DNA methylation.Cubilin expression is monoallelic and epigenetically augmented via PPARs.Perinatal nicotine exposure suppresses PPARγ epigenetically in lung alveolar interstitial fibroblasts.Inhibition of HDAC3 promotes ligand-independent PPARγ activation by protein acetylationEpigenetic Activity of Peroxisome Proliferator-Activated Receptor Gamma Agonists Increases the Anticancer Effect of Histone Deacetylase Inhibitors on Multiple Myeloma Cells.Coordinated Regulation of PPARγ Expression and Activity through Control of Chromatin Structure in Adipogenesis and Obesity.Solution Structures of PPARγ2/RXRα Complexes.Arachidonic and oleic acid exert distinct effects on the DNA methylome.Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndromeOrganization of nuclear architecture during adipocyte differentiation.PPARγ signaling and metabolism: the good, the bad and the future.The effects of rosiglitazone on osteoblastic differentiation, osteoclast formation and bone resorption.MicroRNAs-Dependent Regulation of PPARs in Metabolic Diseases and Cancers.Recent advance in brown adipose physiology and its therapeutic potential.Prolonged high-fat diet induces gradual and fat depot-specific DNA methylation changes in adult mice.Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside.Epigenetic developmental programs and adipogenesis: implications for psychotropic induced obesity.Epigenetics and human obesity.Regulation of histone methylation by noncoding RNAs.Living long and ageing well: is epigenomics the missing link between nature and nurture?Interaction of 17β-estradiol and dietary fatty acids on energy and glucose homeostasis in female mice.The peroxisome proliferator-activated receptors under epigenetic control in placental metabolism and fetal development.A transient disruption of fibroblastic transcriptional regulatory network facilitates trans-differentiationThe Role of PPARγ in the Transcriptional Control by Agonists and Antagonists.Signaling Crosstalk between PPARγ and BMP2 in Mesenchymal Stem CellsDNA methylation patterns of peroxisome proliferator-activated receptor gamma gene associated with liver fibrosis and inflammation in chronic hepatitis B.CACUL1 reciprocally regulates SIRT1 and LSD1 to repress PPARγ and inhibit adipogenesis.Low Neonatal Plasma N-6/N-3 Pufa Ratios Regulate Offspring Adipogenic Potential and Condition Adult Obesity Resistance.Ginkgolic acid, a sumoylation inhibitor, promotes adipocyte commitment but suppresses adipocyte terminal differentiation of mouse bone marrow stromal cells.The potential signaling pathway between peroxisome proliferator-activated receptor gamma and retinoic acid receptor alpha in renal interstitial fibrosis disease.Insulin action and resistance in obesity and type 2 diabetes.
P2860
Q26750525-FA976E5C-9523-4398-A884-7F350868041CQ26764921-FDE0A785-C7B5-4150-9AD5-C328C0601875Q26768588-27FD9980-7B2B-48C6-8642-DBEC77ED5BD8Q26849574-8052B13B-F267-49EB-9B1A-6C6D8D003DB0Q28070220-C2EFA21D-749C-4905-A333-21D214705A95Q28073039-9F109793-5E59-40F3-9774-665F5072657BQ34273620-55FDAB03-E018-4A3E-8254-F82FF98C48E9Q34774905-561D3ADA-9291-479A-AC70-63E980578B01Q35329148-81D5633E-1211-4AD5-A74C-149CFB00B79CQ35338684-79FEF266-3D44-40E4-A5F6-909CBC8249DEQ35668937-B2FC5601-26FF-4698-9A1D-216AED0238D2Q36238874-0606431A-ECF7-4C09-A410-9F15116883B0Q36516065-83379B43-B43E-492D-88CD-E3599550E02DQ36956881-36372393-38D5-4BF4-A06A-FC8423C4BFFDQ36970120-97F660FD-CECB-412E-B312-B1B28FEFCFDAQ37248204-C87B7BD3-EFD8-4F5D-B2F6-C069D98C306FQ37407887-C6E10FBA-7BBE-4334-B53F-2A69DB5EFA1EQ37461510-FC9E4A8E-2915-496C-85F5-7C70F069F6B9Q37607478-28815DB9-362E-4959-80FB-76D938301BFBQ37621009-028731EE-C59F-4D74-8B2E-E459F9848418Q37678973-68F957F6-4D72-40FE-91E6-A2F53D413675Q38018841-3D8A8FED-BCEB-4D66-B3AD-2D3E1427C07BQ38130106-E24D7490-1329-4EBA-A489-37E1DF8A566EQ38190867-E3BF76C5-D59A-4AB6-B716-FFE726B338EFQ38222353-64B79781-2898-4E4A-85E1-B4672434650CQ38541612-B73003F6-324C-4463-9816-27D6EAAAE141Q38689395-C98C31B5-EEC2-4C90-858D-4BCB804764CBQ38727651-4FE59307-EB45-439C-9578-664C0C8EDE0EQ41828957-0766F3DB-53A4-4952-9749-A1941CFFCCE9Q42185295-CECB19A9-50CD-4C02-BB10-BD8CF2A8935AQ42562772-1578CCBA-1C2F-4CC8-B620-828F4C5AD5A2Q44987446-9FFBABF6-FA08-4683-B8F7-F5A669D19736Q47300867-C26A45B9-3D02-4BFA-A268-569006CAC2A3Q50016489-01C1A60C-F277-4F63-82B9-433116995159Q50130005-E002A2F1-63AB-4ED7-AE30-7E4750DA044EQ53007399-2503AD7A-5F03-41ED-B7B3-EFA442A8A6CBQ53733290-4FA3ECDA-0A49-4991-A8D1-97FDD4AC701F
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epigenetic codes of PPARγ in metabolic disease.
@en
Epigenetic codes of PPARγ in metabolic disease.
@nl
type
label
Epigenetic codes of PPARγ in metabolic disease.
@en
Epigenetic codes of PPARγ in metabolic disease.
@nl
prefLabel
Epigenetic codes of PPARγ in metabolic disease.
@en
Epigenetic codes of PPARγ in metabolic disease.
@nl
P2860
P1433
P1476
Epigenetic codes of PPARγ in metabolic disease.
@en
P2093
Shigeki Sugii
P2860
P304
P356
10.1016/J.FEBSLET.2011.05.007
P407
P577
2011-05-19T00:00:00Z